Merck wins first FDA approval for Keytruda as a treatment for mesothelioma

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.

Source: MarketWatch

Continue reading...